JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Shanghai Stock Exchange 600200.SS

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue for the year ending December 31, 2023: USD 315.50 M

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue is USD 315.50 M for the year ending December 31, 2023, a 7.45% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue for the year ending December 31, 2022 was USD 293.62 M, a 5.08% change year over year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue for the year ending December 31, 2021 was USD 279.42 M, a -2.56% change year over year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue for the year ending December 31, 2020 was USD 286.75 M, a -5.36% change year over year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. Revenue for the year ending December 31, 2019 was USD 302.97 M, a 22.46% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Shanghai Stock Exchange: 600200.SS

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

CEO Mr. Qunshan Qian
IPO Date April 1, 1999
Location China
Headquarters 988 Dongfang Avenue
Employees 1,050
Sector Health Care
Industries
Description

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.

Similar companies

600183.SS

Shengyi Technology Co.,Ltd.

USD 3.47

3.21%

600201.SS

Jinyu Bio-technology Co., Ltd.

USD 0.89

2.52%

600172.SS

Henan Huanghe Whirlwind Co., Ltd.

USD 0.60

6.53%

600185.SS

Gree Real Estate Co., Ltd

USD 0.85

4.54%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.65

1.42%

StockViz Staff

January 15, 2025

Any question? Send us an email